• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How should the law respond to emerging infectious diseases: China's experience and considerations in containing COVID-19.

作者信息

Yang Chenyu, Li Xuan

出版信息

J Glob Health. 2024 Jun 14;14:03028. doi: 10.7189/jogh.14.03028.

DOI:10.7189/jogh.14.03028
PMID:38867679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11170232/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaae/11170232/9900e265e5a5/jogh-14-03028-Fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaae/11170232/9900e265e5a5/jogh-14-03028-Fa.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaae/11170232/9900e265e5a5/jogh-14-03028-Fa.jpg

相似文献

1
How should the law respond to emerging infectious diseases: China's experience and considerations in containing COVID-19.法律应如何应对新发传染病：中国在防控新冠疫情中的经验与思考
J Glob Health. 2024 Jun 14;14:03028. doi: 10.7189/jogh.14.03028.
2
COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned.全球 COVID-19 紧急情况：中国控制 COVID-19 的经验和教训。
Int J Qual Health Care. 2021 Feb 20;33(1). doi: 10.1093/intqhc/mzaa143.
3
What can the world learn from China's response to covid-19?中国应对新冠疫情的经验对世界有何启示？
BMJ. 2021 Dec 1;375:n2806. doi: 10.1136/bmj.n2806.
4
Importance of public health tools in emerging infectious diseases.突发传染病中公共卫生工具的重要性。
BMJ. 2021 Dec 1;375:n2374. doi: 10.1136/bmj.n2374.
5
To halt the spread of imported coronavirus disease 2019 cases in China: Action and challenges.遏制中国境外输入新型冠状病毒肺炎病例的传播：行动与挑战
Travel Med Infect Dis. 2021 Jan-Feb;39:101913. doi: 10.1016/j.tmaid.2020.101913. Epub 2020 Nov 7.
6
Research and Development of Medical Countermeasures for Emerging Infectious Diseases, China, 1990-2022.中国1990 - 2022年新发传染病医学应对措施的研发
Emerg Infect Dis. 2025 Jan;31(1):14-21. doi: 10.3201/eid3101.230638.
7
5. Infectious disease surveillance designated by the Infectious Disease Control Law, and the situation of emerging/re-emerging infectious diseases in Japan.5. 《传染病防治法》规定的传染病监测，以及日本新出现/再次出现的传染病情况。
Intern Med. 2002 Jan;41(1):61-2. doi: 10.2169/internalmedicine.41.61.
8
China's COVID-19 response for the protection of rural communities.中国为保护农村社区应对新冠疫情的举措。
PLoS Negl Trop Dis. 2021 Feb 2;15(2):e0009018. doi: 10.1371/journal.pntd.0009018. eCollection 2021 Feb.
9
Emerging infectious diseases and the law.新发传染病与法律
Emerg Infect Dis. 2001;7(3 Suppl):543. doi: 10.3201/eid0707.017722.
10
Policy disparities in response to the first wave of COVID-19 between China and Germany.中国和德国在应对新冠疫情第一波冲击时的政策差异。
Int J Equity Health. 2021 Mar 25;20(1):86. doi: 10.1186/s12939-021-01424-3.

引用本文的文献

1
Surveillance System for Infectious Disease Prevention and Management: Direction of Korea's Infectious Disease Surveillance System.传染病预防与管理监测系统：韩国传染病监测系统的发展方向
J Korean Med Sci. 2025 Mar 3;40(8):e108. doi: 10.3346/jkms.2025.40.e108.

本文引用的文献

1
Early warning signals for Omicron outbreaks in China: A retrospective study.中国奥密克戎疫情的早期预警信号：一项回顾性研究。
J Med Virol. 2023 Jan;95(1):e28341. doi: 10.1002/jmv.28341.
2
Attributes of national governance for an effective response to public health emergencies: Lessons from the response to the COVID-19 pandemic.应对突发公共卫生事件的国家治理特征：从应对 COVID-19 大流行中获得的经验教训。
J Glob Health. 2022 Jul 6;12:05021. doi: 10.7189/jogh.12.05021.
3
Overview of Legal Measures for Managing Workplace COVID-19 Infection Risk in Several Asia-Pacific Countries.
几个亚太国家管理工作场所新冠病毒感染风险的法律措施概述
Saf Health Work. 2021 Dec;12(4):530-535. doi: 10.1016/j.shaw.2021.08.003. Epub 2021 Aug 26.
4
Quarantine an effective mode for control of the spread of COVID19? A review.隔离是控制新冠病毒传播的有效方式吗？一篇综述。
J Family Med Prim Care. 2020 Aug 25;9(8):3867-3871. doi: 10.4103/jfmpc.jfmpc_785_20. eCollection 2020 Aug.
5
The Fear of COVID-19 Scale: Development and Initial Validation.《COVID-19恐惧量表：编制与初步验证》
Int J Ment Health Addict. 2022;20(3):1537-1545. doi: 10.1007/s11469-020-00270-8. Epub 2020 Mar 27.
6
The outbreak of COVID-19: An overview.COVID-19 疫情概述。
J Chin Med Assoc. 2020 Mar;83(3):217-220. doi: 10.1097/JCMA.0000000000000270.
7
The psychological impact of quarantine and how to reduce it: rapid review of the evidence.隔离的心理影响及其减轻方法：快速综述证据。
Lancet. 2020 Mar 14;395(10227):912-920. doi: 10.1016/S0140-6736(20)30460-8. Epub 2020 Feb 26.
8
Infectious disease-related laws: prevention and control measures.传染病相关法律：预防与控制措施。
Epidemiol Health. 2017 Jul 25;39:e2017033. doi: 10.4178/epih.e2017033. eCollection 2017.
9
Emerging infectious diseases: A proactive approach.新发传染病：主动应对。
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4055-4059. doi: 10.1073/pnas.1701410114. Epub 2017 Apr 10.
10
Evidence and effectiveness in decisionmaking for quarantine.检疫决策中的证据与有效性。
Am J Public Health. 2007 Apr;97 Suppl 1(Suppl 1):S44-8. doi: 10.2105/AJPH.2005.077305. Epub 2007 Apr 5.